Latest filing published 02 Mar 2016 for CEMPRA, INC., €7,430.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David Moore: trading record in brief
David Moore discloses dealings in 2 companies, chiefly Cempra, Inc. and Ocera Therapeutics, Inc. The record holds 3 filings, for trades running from 30 September 2011 to 1 March 2016.
Every open-market trade on record is a purchase: 2 purchases worth €9,424, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant. Since January 2016: 1 purchase and no sales on the market.
The latest filing, published on 2 March 2016, reports an open-market purchase of €7,430 in Cempra, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Moore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ US$16.18100.0% of flowCommon StockSEC:0001209191-16-104442:0Canonical exit: 30 May 2016 (T+90)
- 1,000 shares@ US$32.59Common StockSEC:0001209191-15-023280:0
- 1,050 shares@ US$2.58Common StockSEC:0001104659-11-054800:0Canonical exit: 29 Dec 2011 (T+90)
3 of 3 declarations
